Cancer DNA in the Circulation: The Liquid Biopsy.
作者信息
Husain Hatim, Velculescu Victor E
机构信息
Division of Hematology and Oncology, Moores Cancer Center, University of California, San Diego, La Jolla.
The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
出版信息
JAMA. 2017 Oct 3;318(13):1272-1274. doi: 10.1001/jama.2017.12131.
Abstract
摘要
相似文献
1
Cancer DNA in the Circulation: The Liquid Biopsy.循环中的癌症DNA：液体活检
JAMA. 2017 Oct 3;318(13):1272-1274. doi: 10.1001/jama.2017.12131.
2
The tumour trail left in blood.血液中留下的肿瘤踪迹。
Nature. 2016 Apr 14;532(7598):269-71. doi: 10.1038/532269a.
3
Going With the Flow: The Promise and Challenge of Liquid Biopsies.顺应潮流：液体活检的前景与挑战
JAMA. 2017 Sep 26;318(12):1095-1097. doi: 10.1001/jama.2017.10203.
4
Liquid cancer biopsy: the future of cancer detection?液体癌症活检：癌症检测的未来？
Lancet Oncol. 2016 Feb;17(2):123. doi: 10.1016/S1470-2045(16)00016-4.
5
Medicine. Keeping tabs on tumor DNA.医学。密切关注肿瘤DNA。
Science. 2010 Feb 26;327(5969):1074. doi: 10.1126/science.327.5969.1074.
6
Reliable results from several DNA sources.来自多个DNA来源的可靠结果。
Nat Rev Clin Oncol. 2019 Jun;16(6):335. doi: 10.1038/s41571-019-0208-2.
7
Circulating methylated DNA.循环甲基化DNA
Ann N Y Acad Sci. 2004 Jun;1022:33-9. doi: 10.1196/annals.1318.006.
8
Liquid Biopsy Holds Its Own in Tumor Profiling.液体活检在肿瘤分析中独树一帜。
Cancer Discov. 2016 Jul;6(7):686. doi: 10.1158/2159-8290.CD-NB2016-070. Epub 2016 Jun 10.
9
[Circulating cell-free DNA as biomarker for cancer *header*].[循环游离DNA作为癌症生物标志物*标题*]
Duodecim. 2015;131(5):424-32.
10
[Update on new techniques for the molecular diagnosis of cancer].[癌症分子诊断新技术的更新]
Ann Pathol. 2008 Nov;28 Spec No 1(1):S71-6. doi: 10.1016/j.annpat.2008.09.022. Epub 2008 Oct 15.
引用本文的文献
1
Biomarker-informed care for patients with renal cell carcinoma.肾细胞癌患者的生物标志物指导治疗
Nat Cancer. 2025 Apr;6(4):573-583. doi: 10.1038/s43018-025-00942-1. Epub 2025 Apr 16.
2
The ctDNA revolution: Insights on cancer care: A narrative review.循环肿瘤DNA的变革：癌症治疗见解：一篇叙述性综述
Bioinformation. 2024 Oct 31;20(10):1287-1290. doi: 10.6026/9732063002001287. eCollection 2024.
3
Genomic and fragmentomic landscapes of cell-free DNA for early cancer detection.用于早期癌症检测的游离DNA的基因组和片段组图谱。
Nat Rev Cancer. 2025 May;25(5):341-358. doi: 10.1038/s41568-025-00795-x. Epub 2025 Mar 4.
4
Potentialities and critical issues of liquid biopsy in clinical practice: An umbrella review.液体活检在临床实践中的潜力与关键问题：一项综合综述。
Transl Oncol. 2025 Feb;52:102172. doi: 10.1016/j.tranon.2024.102172. Epub 2025 Jan 15.
5
Landscape of Biomarkers and Pathologic Response in Rectal Cancer: Where We Stand?直肠癌生物标志物与病理反应概况：我们目前的状况如何？
Cancers (Basel). 2024 Dec 2;16(23):4047. doi: 10.3390/cancers16234047.
6
Analytical and clinical validation of a NGS panel in detecting targetable variants from ctDNA of metastatic NSCLC patients.对一种用于检测转移性非小细胞肺癌患者 ctDNA 中可靶向变异的 NGS panel 的分析和临床验证。
Cancer Med. 2024 Oct;13(19):e70078. doi: 10.1002/cam4.70078.
7
Evaluation of blood MSI burden dynamics to trace immune checkpoint inhibitor therapy efficacy through the course of treatment.评估血液 MSI 负担动态，以追踪免疫检查点抑制剂治疗疗效在治疗过程中的变化。
Sci Rep. 2024 Oct 8;14(1):23454. doi: 10.1038/s41598-024-73952-1.
8
Molecular features of NSCLC patients with liver metastasis.非小细胞肺癌肝转移患者的分子特征。
Ther Adv Med Oncol. 2024 Sep 24;16:17588359241275421. doi: 10.1177/17588359241275421. eCollection 2024.
9
Advances in Liquid Biopsy for Diagnosis of Bladder Cancer.用于膀胱癌诊断的液体活检进展
Int Neurourol J. 2024 Jun;28(2):83-95. doi: 10.5213/inj.2448198.099. Epub 2024 Jun 30.
10
Recent Advances and Future Challenges in Pancreatic Cancer Care: Early Detection, Liquid Biopsies, Precision Medicine and Artificial Intelligence.胰腺癌治疗的最新进展与未来挑战：早期检测、液体活检、精准医学与人工智能
J Clin Med. 2023 Dec 4;12(23):7485. doi: 10.3390/jcm12237485.
本文引用的文献
1
Direct detection of early-stage cancers using circulating tumor DNA.利用循环肿瘤DNA直接检测早期癌症。
Sci Transl Med. 2017 Aug 16;9(403). doi: 10.1126/scitranslmed.aan2415.
2
Finding the Rare Pathogenic Variants in a Human Genome.在人类基因组中寻找罕见的致病变异体。
JAMA. 2017 May 9;317(18):1904-1905. doi: 10.1001/jama.2017.0432.
3
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.一种用于定量循环肿瘤DNA的超灵敏方法，具有广泛的患者覆盖范围。
Nat Med. 2014 May;20(5):548-54. doi: 10.1038/nm.3519. Epub 2014 Apr 6.
4
Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA.利用游离血浆DNA的定量下一代基因分型对EGFR突变型肺癌的反应和耐药性进行无创检测。
Clin Cancer Res. 2014 Mar 15;20(6):1698-1705. doi: 10.1158/1078-0432.CCR-13-2482. Epub 2014 Jan 15.
5
Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing.用全基因组测序技术检测癌症患者循环中的染色体改变。
Sci Transl Med. 2012 Nov 28;4(162):162ra154. doi: 10.1126/scitranslmed.3004742.
6
Detection and quantification of rare mutations with massively parallel sequencing.大规模平行测序检测和定量稀有突变。
Proc Natl Acad Sci U S A. 2011 Jun 7;108(23):9530-5. doi: 10.1073/pnas.1105422108. Epub 2011 May 17.
7
[Nuclear Acids In Human Blood Plasma].[人血浆中的核酸]
C R Seances Soc Biol Fil. 1948 Feb;142(3-4):241-3.
8
Digital PCR.数字PCR
Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9236-41. doi: 10.1073/pnas.96.16.9236.
9
Nucleic acid-based methods for the detection of cancer.基于核酸的癌症检测方法。
Science. 1997 Nov 7;278(5340):1054-9. doi: 10.1126/science.278.5340.1054.
Zotero 插件